Overview
Xuelei Ruan practices practicing medicine in Shenyang, China.
Ruan is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Glioma, Gliomatosis Cerebri, Glioblastoma, and Astrocytoma.
They are actively involved in clinical research, co-authoring 53 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xuelei Ruan
Is Xuelei Ruan a top-rated expert for Glioma?
MediFind is an objective health platform that identifies experts based on real-world data. Xuelei Ruan is classified as an Advanced expert for Glioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xuelei Ruan participate in research or clinical trials?
Yes. Xuelei Ruan has published 53 articles and abstracts on conditions like Glioma. You can view a list of Xuelei Ruan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AstrocytomaRuan isAdvanced. Learn about Astrocytoma.
- Brain TumorRuan isAdvanced. Learn about Brain Tumor.
- GlioblastomaRuan isAdvanced. Learn about Glioblastoma.
- GliomaRuan isAdvanced. Learn about Glioma.
- Gliomatosis CerebriRuan isAdvanced. Learn about Gliomatosis Cerebri.